ADAPTIN BIO, INC.
Datakwaliteit: 67%
APTN
OTC
Manufacturing
Chemicals
Quick Summary
Belangrijkste Punten
Negative free cash flow of -4,78 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio0,53
Interest Coverage-74,53
Waardering
P/E Ratio
N/A
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | — | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -5,17 M |
| ROE | N/A | ROA | -391,17% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -4,78 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,53 |
| Interest Coverage | -74,53 | Asset Turnover | N/A |
| Working Capital | -881.078 | Tangible Book Value | -881.078 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | N/A | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | N/A | ||
| Market Cap | N/A | Enterprise Value | N/A |
| Per Share | |||
| EPS (Diluted TTM) | -0,66 | Revenue / Share | N/A |
| FCF / Share | N/A | OCF / Share | N/A |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 92,46% |
| SBC-Adj. FCF | -5,10 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | — | — | — |
| Net Income | -5,17 M | -161.160,0 | -85.593,0 |
| EPS (Diluted) | -0,66 | -0,03 | -0,02 |
| Gross Profit | — | — | — |
| Operating Income | -5,41 M | -155.374,0 | — |
| EBITDA | — | — | — |
| R&D Expenses | 1,77 M | — | — |
| SG&A Expenses | — | — | — |
| D&A | — | — | — |
| Interest Expense | 72.659,0 | 5.786,0 | — |
| Income Tax | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 619.159,0 | 12.619,0 | 380,0 |
| Total Liabilities | 2,11 M | 286.676,0 | 113.277,0 |
| Shareholders' Equity | -1,49 M | -274.057,0 | -112.897,0 |
| Total Debt | — | — | — |
| Cash & Equivalents | 459.174,0 | — | 380,0 |
| Current Assets | 619.159,0 | 12.619,0 | 380,0 |
| Current Liabilities | 2,11 M | 286.676,0 | 113.277,0 |
{"event":"ticker_viewed","properties":{"ticker":"APTN","listing_kind":"stock","pathname":"/stocks/aptn","exchange":"OTC","country":"US"}}